You are here

Session on Cardio-nephrology: renal toxicities

By Eric P. Cohen, recorded at TAO (Transatlantic Oncology meeting), Nov 20-21, 2014, Paris

4 - Eric Cohen ANG

Collaboration between oncologists and nephrologists is important in the renal field, as there is a bidirectional association. On the one hand, the kidney can have an impact on cancer and its treatment: it has been shown, for example, that the incidence of cancer increases after kidney transplantation. Besides, impaired renal function may require dose reductions, and some drugs are contraindicated in renal failure. However, as most clinical trials exclude patients with chronic renal failure, there is a lack of data in this field. On the other hand, cancer can have an impact on the kidneys (for example, kidney cancer or paraneoplastic syndrome), while cancer treatment can induce renal toxicities. Eric P. Cohen reviews this interaction, also discussing the glomerular filtration rate.

Eric P. Cohen, Medical College of Wisconsin, Milwaukee, USA

Search this site

Featured videos

Free access to ebooks on cachexia and CINV

 

Prevention of nausea and vomiting in
adult cancer patients receiving tumour-
directed therapy – 2017 update –

and
Cancer cachexia: mechanisms and progress in treatment

 

Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo

Share